Neuraxis
NRXS
8 hedge funds and large institutions have $233K invested in Neuraxis in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.
16% more capital invested
Capital invested by funds: $201K → $233K (+$31.2K)
14% more funds holding
Funds holding: 7 → 8 (+1)
0.02% less ownership
Funds ownership: 1.43% → 1.41% (-0.02%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$637 |
| 2 |
JP Morgan Chase
New York
|
+$12 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.47K |
| 2 |
Wells Fargo
San Francisco,
California
|
-$3 |
NRXS Hedge Fund Activity: Q1 2024 in Review
8 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Neuraxis (NRXS) for Q1 2024, worth a combined $233K — up 16% from $201K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new NRXS positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $637. The largest seller was Tower Research Capital (TRC), cutting an estimated $3.47K.
- 8 institutional investors held Neuraxis (NRXS) as of Q1 2024, up from 7 in Q4 2023.
- Funds reported $233K of Neuraxis stock for Q1 2024, up 16% quarter-over-quarter.
- 1 fund opened new Neuraxis positions in Q1 2024 and 0 closed out, a net change of +1 holder.
- The largest Neuraxis buyer in Q1 2024 was UBS Group, an estimated $637 added.
- The largest Neuraxis seller in Q1 2024 was Tower Research Capital (TRC), an estimated $3.47K sold.
Based on aggregated 13F filings for Q1 2024.